Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Ertel

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|April 2, 2013
Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3Ethan V Abel, Kevin J Basile, Curtis H Kugel, et al.
Theranostics|May 4, 2018
Cyclin D1-mediated microRNA expression signature predicts breast cancer outcomeGuangxue Wang, Michael Gormley, Jing Qiao, et al.
Nature Communications|November 30, 2013
Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancerZuoren Yu, Liping Wang, Chenguang Wang, et al.
The Journal of Clinical Investigation|February 7, 2012
ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in miceMathew C Casimiro, Marco Crosariol, Emanuele Loro, et al.
Frontiers in Immunology|June 21, 2021
IFN-β Acts on Monocytes to Ameliorate CNS Autoimmunity by Inhibiting Proinflammatory Cross-Talk Between Monocytes and Th CellsJavad Rasouli, Giacomo Casella, Larissa L W Ishikawa, et al.
Cancer Discovery|March 3, 2018
<i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Cancer Research|March 16, 2013
Dachshund binds p53 to block the growth of lung adenocarcinoma cellsKe Chen, Kongming Wu, Shaoxin Cai, et al.
Cancer Discovery|December 5, 2018
Correction: <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Cancer Research|September 17, 2016
v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1Xiaoming Ju, Xuanmao Jiao, Adam Ertel, et al.
Oncotarget|May 6, 2015
Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesisMathew C Casimiro, Gabriele Di Sante, Marco Crosariol, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|April 2, 2013
Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3Ethan V Abel, Kevin J Basile, Curtis H Kugel, et al.
Theranostics|May 4, 2018
Cyclin D1-mediated microRNA expression signature predicts breast cancer outcomeGuangxue Wang, Michael Gormley, Jing Qiao, et al.
Nature Communications|November 30, 2013
Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancerZuoren Yu, Liping Wang, Chenguang Wang, et al.
The Journal of Clinical Investigation|February 7, 2012
ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in miceMathew C Casimiro, Marco Crosariol, Emanuele Loro, et al.
Frontiers in Immunology|June 21, 2021
IFN-β Acts on Monocytes to Ameliorate CNS Autoimmunity by Inhibiting Proinflammatory Cross-Talk Between Monocytes and Th CellsJavad Rasouli, Giacomo Casella, Larissa L W Ishikawa, et al.
Cancer Discovery|March 3, 2018
<i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Cancer Research|March 16, 2013
Dachshund binds p53 to block the growth of lung adenocarcinoma cellsKe Chen, Kongming Wu, Shaoxin Cai, et al.
Cancer Discovery|December 5, 2018
Correction: <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Cancer Research|September 17, 2016
v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1Xiaoming Ju, Xuanmao Jiao, Adam Ertel, et al.
Oncotarget|May 6, 2015
Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesisMathew C Casimiro, Gabriele Di Sante, Marco Crosariol, et al.
Pageof 9